CTLA-4 as a Double-Edged Sword in Colorectal Cancer: Molecular Insights into Immune Checkpoint Suppression and Therapeutic Targeting

Husin Thamrin, Gondo Mastutik, Muhammad Miftahussurur

Open source

DOI
10.5009/gnl260025
Published
2026-08-31
Container
Gut and Liver
Publisher
The Editorial Office of Gut and Liver
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5009/gnl260025,
  title = {CTLA-4 as a Double-Edged Sword in Colorectal Cancer: Molecular Insights into Immune Checkpoint Suppression and Therapeutic Targeting},
  author = {Husin Thamrin and Gondo Mastutik and Muhammad Miftahussurur},
  year = {2026},
  journal = {Gut and Liver},
  doi = {10.5009/gnl260025},
  url = {https://doi.org/10.5009/gnl260025}
}

RIS

TY  - JOUR
TI  - CTLA-4 as a Double-Edged Sword in Colorectal Cancer: Molecular Insights into Immune Checkpoint Suppression and Therapeutic Targeting
AU  - Husin Thamrin
AU  - Gondo Mastutik
AU  - Muhammad Miftahussurur
PY  - 2026
JO  - Gut and Liver
DO  - 10.5009/gnl260025
UR  - https://doi.org/10.5009/gnl260025
ER  - 

APA

Thamrin, H., Mastutik, G., & Miftahussurur, M. (2026). CTLA-4 as a Double-Edged Sword in Colorectal Cancer: Molecular Insights into Immune Checkpoint Suppression and Therapeutic Targeting. Gut and Liver. https://doi.org/10.5009/gnl260025

Source records